Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02303470 · ClinicalTrials.gov registry record · NA

PCOS & Insulin Resistance Exercise Study

A NA study of Insulin Resistance and Polycystic Ovary Syndrome, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT02303470 is a NA study of Insulin Resistance and Polycystic Ovary Syndrome that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02303470, a NA study of Insulin Resistance and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized to either 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week.

Interventions

  • BEHAVIORAL Vigorous Exercise
  • BEHAVIORAL Moderate Exercise

Study Locations (1)

California

  • UCSF Center for Reproductive Health - San Francisco

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2015-03
Est. Completion 2025-02
Phase NA

What the Registry Record Tells You About NCT02303470

The ClinicalTrials.gov registry entry for NCT02303470 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (81% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which Vigorous Exercise is the first listed.

NCT02303470 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02303470 about?

NCT02303470 is a clinical study titled "PCOS & Insulin Resistance Exercise Study". This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized to either 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week.

What is the current status of trial NCT02303470?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 47 participants. The study started on 2015-03. Estimated completion is 2025-02.

What conditions does trial NCT02303470 study?

This clinical trial studies the following conditions: Insulin Resistance, Polycystic Ovary Syndrome.

What interventions are being tested in trial NCT02303470?

The interventions under investigation include: Vigorous Exercise (BEHAVIORAL), Moderate Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02303470?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02303470 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.